Notably, NAA40-mediated activation of the 1C-metabolic gene TYMS confers 5-FU resistance to CRC cells and in human colorectal tumours NAA40 expression positively correlates with TYMS levels and worse response of patients to 5-FU-based chemotherapy. Here, NAA40 is linked to colorectal carcinoma.